Crescent Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 10-07-2024
- Paid Up Capital ₹ 0.21 M
as on 10-07-2024
- Company Age 27 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.15 Cr
as on 10-07-2024
- Revenue %
(FY 2023)
- Profit -178.70%
(FY 2023)
- Ebitda -126.86%
(FY 2023)
- Net Worth -4.56%
(FY 2023)
- Total Assets -1.41%
(FY 2023)
About Crescent Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.21 M.
The company currently has active open charges totaling ₹16.15 Cr.
Sibesh Dubey and Samyo Pratik serve as directors at the Company.
- CIN/LLPIN
U24119WB1997PTC082797
- Company No.
082797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 1997
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Crescent Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samyo Pratik  | Director | 04-Mar-2021 | Current |
| Sibesh Dubey | Director | 01-Aug-2002 | Current |
Financial Performance of Crescent Pharmaceuticals.
Crescent Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 178.7% decrease in profit. The company's net worth dipped by a decrease of 4.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crescent Pharmaceuticals?
Unlock access to Crescent Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Calprin Ads Private LimitedActive 25 years 10 monthsSibesh Dubey and Samyo Pratik are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 30 Mar 2015 | ₹16.15 Cr | Open |
How Many Employees Work at Crescent Pharmaceuticals?
Unlock and access historical data on people associated with Crescent Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crescent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
